Vigil Neuroscience Competitors and Similar CompaniesClear all

Vigil Neuroscience's competitors and similar companies include Absci, e-therapeutics, Domain Therapeutics and Redesign Science.

	Vigil Neuroscience Vigil Neuroscience is a company that discovers therapeutics for neurodegenerative diseases.	Absci AbSci is a company that provides generative AI drug-creation solutions.	e-therapeutics e-therapeutics is a computational drug discovery company.	Domain Therapeutics Domain Therapeutics is a biopharmaceutical company.	Redesign Science Redesign Science is a computational chemistry company specializing in small molecule drug discovery.
Founding Date	Founding Date 2020	Founding Date 2011	Founding Date 2003	Founding Date 2001	Founding Date 2017
Type	Type Public	Type Public	Type Private	Type Private	Type Private
Tags	Tags Technology biotech drug development pharma	Tags Technology artificial intelligence biotech drug development platform	Tags Technology biotech drug development pharma	Tags Technology biotech drug development pharma	Tags Technology biotech drug development pharma
Locations	Locations Cambridge, US HQ	Locations Vancouver, US HQ Belgrade, RS Zug, CH New York, US	Locations Long Hanborough, GB HQ Newcastle Upon Tyne, GB	Locations Illkirch-Graffenstaden, FR HQ Montréal, CA	Locations New York, US HQ
Employees	Employees 34	Employees 1561% increase	Employees 58	Employees 811% decrease	Employees 7
Valuation ($)	Valuation ($) 151.5 m	Valuation ($) 487.2 m	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $2.8m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A
Net income	Net income ($84.3m) (FY, 2024)	Net income ($115.2m) (FY, 2025)	Net income (£14.9m) (FY, 2025)	Net income N/A	Net income N/A
Funding
Latest funding round	Latest funding round N/A	Latest funding round N/A	Latest funding round N/A	Latest funding round $ 3.9m (about 7 years ago)	Latest funding round $ 2m (over 6 years ago)
Total funding raised	Total funding raised $ 140m	Total funding raised $ 217.5m	Total funding raised $ 66.8m	Total funding raised $ 41.5m	Total funding raised $ 2m